Bengaluru: A hospital in Bengaluru has successfully performed the heart transplant surgery on a 10-month infant giving it a new lease of life. The rare surgery was ...

The Wistar Institute's Nan Zhang, Ph.D., assistant professor in the Ellen and Ronald Caplan Cancer Center's Molecular and ...

“Our work has opened the door to a possible new method of treating a particularly aggressive cancer,” said Brennah Murphy, Ph.D., first author of the paper. “Ovarian cancer is infamous for resisting ...

Pharmanovia partners with Lindis Biotech to commercialise catmaxomab to treat rare condition, malignant ascites: Basildon, UK Thursday, November 21, 2024, 17:00 Hrs [IST] Pharmano ...

The government has launched a review of the role of physician associates (PAs) after concerns were raised about patient safety ...

Liver cancer is responsible for thousands of deaths each year - but one of the early symptoms is often ignored or mistaken ...

Pharmanovia has signed a licensing agreement with Lindis Biotech to commercialise catumaxomab, a new trifunctional ...

Joseph Ambani, a Medical Doctor at GlowBar, has shared the top symptom for liver cancer which can be spotted during the early ...

There is a growing global burden of liver disease with the current management for complications of liver cirrhosis being reactive as opposed to proactive, affecting outcomes. Management can often be ...

Lindis Biotech has licensed Korjuny (catumaxomab) to Pharmanovia for malignant ascites, offering a targeted immune therapy ...

Catumaxomab received a positive opinion from the EMA's Committee for Medicinal Products for Human Use (CHMP) at its October 2024 meeting and if approved catumaxomab will be the only approved drug for ...